✦ LIBER ✦

Peptide vaccines for hematological malignancies: a missed promise?

✍ Scribed by Bocchia, Monica; Defina, Marzia; Aprile, Lara; Sicuranza, Anna

Book ID: 121555036
Publisher: Carden Jennings Publishing
Year: 2014
Tongue: English
Weight: 374 KB
Volume: 99
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-013-1497-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amsacrine: a new drug for hematological

Amsacrine: a new drug for hematological malignancies

✍ McCredie, Kenneth B. 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 296 KB

PR1 peptide vaccine promising for myeloi

PR1 peptide vaccine promising for myeloid leukaemia

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Promise and challenges of peptide-poly:

Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas

✍ Hideho Okada,Lisa H Butterfield,Ronald L Hamilton… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 65 KB

Survivin-derived peptide epitopes and th

Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies

✍ Friedrichs, Birte; Siegel, Sandra; Hald Andersen, Mads; Schmitz, Norbert; Zeis, 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 116 KB

A role for PKR in hematologic malignanci

A role for PKR in hematologic malignancies

✍ William L. Blalock; Alberto Bavelloni; Manuela Piazzi; Irene Faenza; Lucio Cocco 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

## Abstract The double‐stranded RNA‐dependent kinase PKR has been described for many years as strictly a pro‐apoptotic kinase. Recent data suggest that the main purpose of this kinase is damage control and repair following stress and, if all else fails, apoptosis. Aberrant activation of PKR has bee

Palliative care for patients with hemato

Palliative care for patients with hematological malignancies—a case series

✍ Bernd Alt-Epping; Gerald Wulf; Friedemann Nauck 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 72 KB